本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

NovoCure Limited

17.44
+0.79004.74%
盘后17.440.00000.00%17:47 EDT
成交量:68.16万
成交额:1,186.47万
市值:19.44亿
市盈率:-11.53
高:17.70
开:16.96
低:16.85
收:16.65
数据加载中...
2025/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/17

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/12/02

重要事件披露

Form 8-K - Current report
2024/10/30

重要事件披露

Form 8-K - Current report
2024/10/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/15

重要事件披露

Form 8-K - Current report
2024/09/03

重要事件披露

Form 8-K - Current report
2024/07/25

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/25

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/25

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/25

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/25

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/25

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/25

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/25

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/25

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/25

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]